The Rb family of proteins, which consists of Rb, p107 and p130, are critical regulators of cell proliferation. In addition to their inhibitory effects on cell cycle progression, Rb-family proteins repress transcription by RNA polymerases I and III, and may therefore restrain cell growth. However, it is not known if Rb, p107 or p130 have direct effects on protein synthesis. Here we report that ectopic expression of p107 in rat fibroblasts markedly attenuates the stimulation of mRNA translation and global protein synthesis by serum growth factors. This effect is associated with a reduction in the phosphorylation and activation of the serine-threonine kinases Akt1 and p70 S6 kinase (S6K1), two downstream targets of phosphoinositide-dependent kinase 1 (PDK1). We show that overexpression of p107 interferes with the recruitment of PDK1 to the plasma membrane in response to growth factors. Overexpression of PDK1 restores the defect in translation elicited by p107. These results suggest that p107 restricts cell growth by interfering with the phosphoinositide 3-kinase (PI3K) signaling pathway.
Introduction
The Rb family of proteins, which consists of Rb, p107 and p130, are important regulators of the mammalian cell cycle (Grana et al., 1998; Harbour and Dean, 2000; Mulligan and Jacks, 1998) . They act in part by binding to E2F transcription factors, resulting in transcriptional inhibition or active repression of genes required for G1 to S phase transition (Dyson, 1998; Nevins, 1998) . In addition to their effects on the cell cycle, Rbfamily proteins also inhibit transcription by RNA polymerases I and III, and may therefore control the biosynthetic capacity of cells (Sutcliffe et al., 1999; White, 1997) . To investigate whether the Rb-family protein p107 is linked to protein synthesis control, we have established Rat1 fibroblast cell lines that overexpress p107 (Figure 1a ). Rat1-p107 cells proliferate more slowly than parental Rat1 cells. Consistent with previous observations (Zhu et al., 1993) , we found that expression of p107 increases the percentage of cells in G1 and prolong the transition from G0 to S phase upon cell cycle reentry (data not shown). To evaluate the impact of p107 overexpression on global protein synthesis, quiescent Rat1 and Rat1-p107 cells were stimulated with serum and pulse labeled with 3 Hleucine for 2 h. The rate of protein synthesis was reduced by approximately threefold in Rat1-p107 cells as compared to their Rat1 counterpart (Figure 1b) . Similar results were obtained when populations of Rat1 cells were infected with a p107-expressing retrovirus (Figure 1c) , confirming that the effect of p107 is not an artefact of clonal selection. To determine whether the inhibitory effect of p107 on global protein synthesis is associated with changes in translation rates, we used a luciferase mRNA reporter assay. Control and Rat1-p107 cells were transiently transfected with the luciferase gene driven by a CMV promoter (Beretta et al., 1996) , serum-starved for 24 h, and then restimulated with serum for 2 h. Addition of serum increased the rate of luciferase mRNA translation by 4.9-fold in Rat1 cells as compared to 1.8-fold in cells overexpressing p107 (Figure 1d ). This effect was not due to any detrimental change associated with long term p107 expression, as it was reproduced in wild-type Rat1 cells transiently transfected with p107 expression vector (Figure 1e ). The reduction of protein synthesis could not be explained either by an inhibitory effect of p107 on cell survival, since the percentage of apoptotic cells evaluated by TUNEL analysis was less than 10% in serum-deprived cells and negligible in proliferating cells (Figure 1f) . Moreover, no sub-G1 population of cells was visible by FACS analysis (data not shown). Taken together, these results indicate that deregulated Figure 1 Overexpression of p107 inhibits translation and protein synthesis in Rat1 fibroblasts. (a) Rat1 cells were transfected with pCMV-p107HA vector using Lipofectin (Life Technologies) and stably expressing cells were selected in complete medium containing 0.4 mg/ml of G418. Parental Rat1 and Rat1-p107 cells were made quiescent by serum starvation, and then restimulated with 10% serum for the indicated times. The expression level of p107 in parental Rat1 and Rat1-p107 cells was analysed by immunoblotting (Servant et al., 2000) using a specific anti-p107 antibody (Santa-Cruz Biotechnology). (b) Quiescent Rat1 and Rat1-p107 were stimulated or not (time 0) with 10% serum and pulse labeled with 3 H-leucine for 2 h. The rate of global protein synthesis was measured by [ 3 H]leucine incorporation as previously described (Servant et al., 2000) . Results are expressed as per cent stimulation over the basal rate of protein synthesis in control cells. (c) Rat1 cells were infected with control pBabe-puro and pBabe-p107HA retrovirus as described (Pear et al., 1993) . Populations of infected cells were selected for 2 days with 4 mg/ml puromycin and the rate of global protein synthesis was measured as in (b). Ectopic expression of p107HA was confirmed by immunoblotting analysis (data not shown). (d) For assay of in vivo translation rates, Rat1 and Rat1-p107 cells seeded in 24-well plates were transiently transfected with 0.1 mg/well of pcDNA3-Luc/Pol/CAT reporter plasmid (Beretta et al., 1996) . After 24 h, the cells were made quiescent and restimulated with 10% serum for 2 h prior to harvest. Cells were washed with ice-cold PBS and scraped in 150 ml lysis buffer (50 mM TrisHCl, pH 7.8, 1 mM dithiothreitol, 0.1% Triton X-100). Luciferase activity from 100 ml protein lysate was measured after addition of 100 ml luciferase buffer (1 M Tris-HCl, pH 7.8, 1 M MgCl 2 , 0.47 mM ATP) and 100 ml luciferase buffer (0.98 mM D-luciferin, 5 mM KH 2 PO 4 ) using a model 1250 luminometer (Bio-Orbit). The luciferase activity was normalized to the levels of luciferase mRNA estimated by Northern blot analysis. Results are presented as fold stimulation over the basal rate of translation in control cells. Recent studies in mammalian and Drosophila systems have highlighted the importance of PI3K and target of rapamycin (TOR) signaling in the control of translation and cell growth (Dennis et al., 1999; Edgar, 1999; Gingras et al., 2001; Leevers et al., 1996; Oldham et al., 2000; Shioi et al., 2000; Weinkove et al., 1999; Zhang et al., 2000) . To define the molecular basis of p107 inhibitory effect on translation, we examined the activity of downstream effectors of these two signaling pathways. The ribosomal S6 kinases receive inputs from both the PI3K and TOR pathways (Gingras et al., 2001; Volarevic and Thomas, 2000) . These kinases regulate the translation of a group of mRNAs (possessing a 5' terminal oligopyrimidine tract) that code for ribosomal proteins and other components of the translational machinery, such as elongation factors and poly(A) binding proteins (Meyuhas, 2000) . We therefore compared the activation profile of S6K1 in parental and Rat1-p107 cells. Treatment of quiescent Rat1 cells with serum growth factors caused a robust activation of S6K1, which reached a maximum at 15 min (Figure 2a) . Overexpression of p107 resulted in a marked attenuation of S6K1 activation (56% inhibition) by serum. Phosphorylation of S6K1 on Thr-389, located in the linker domain, is a prerequisite for the phosphorylation of Thr-229 in the activation loop, which results in full activation of the kinase (Volarevic and Thomas, 2000) . We used a phosphospecific antibody to monitor the phosphorylation of S6K1 on Thr-389. Immunoblot analysis revealed that phosphorylation of S6K1 on Thr-389 was significantly inhibited in Rat1-p107 cells, concomitantly with the decrease in phosphotransferase activity (Figure 2b) . Interestingly, the abundance of S6K1 protein also decreased in Rat1-p107 cells, although this was not sufficient to explain the reduction in phosphorylation. Thus, the inhibition of S6K1 activity observed in p107-overexpressing cells can be explained in part by a reduction of Thr-389 phosphorylation.
Another downstream effector of the PI3K pathway is the serine/threonine kinase Akt1 (Coffer et al., 1998; Vanhaesebroeck and Alessi, 2000) . To determine whether the activity of Akt1 is affected by p107 expression, we analysed its kinetic of activation by serum growth factors in parental and Rat1-p107 cells. Addition of serum to Rat1 cells caused a rapid activation of Akt1, which was already maximal at 5 min and remained elevated for at least 30 min ( Figure 3a) . As expected, the activation of Akt1 was suppressed by pre-treatment with the PI3K inhibitor LY294002. However, little Akt1 activity was measured in serum-stimulated Rat1-p107 cells, indicating that p107 overexpression restrains the activation of Akt1 (Figure 3a) .
In addition to its recruitment to the plasma membrane, Akt1 needs to be phosphorylated on Thr-308 by PDK1 and on Ser-473 by a yet unknown mechanism for its full activation (Toker and Newton, 2000; Vanhaesebroeck and Alessi, 2000) . We therefore analysed the impact of p107 expression on phosphorylation of these two Akt1 regulatory residues. Serum stimulation of Rat1 cells induced Thr-308 phosphorylation of Akt1 with a kinetic that paralleled enzymatic activation (Figure 3b ). This phosphorylation event was markedly attenuated in Rat1-p107 cells. On the contrary, the induction of Ser-473 phosphorylation by serum was not affected by p107 expression (Figure 3c ). To determine more precisely the site of action of p107, we measured the lipid kinase activity of PI3K. No difference in PI3K activity was observed between parental and Rat1-p107 cells (Figure 3d ), which is in keeping with the phosphorylation of Akt1 on Ser-473 (Alessi et al., 1996) . The total expression level of PTEN was also found to be similar in parental and Rat1-p107 cells (data not shown). Thus, these results indicate that p107 operates downstream of PI3K action.
The study of Balendran et al. (1999) strongly suggests that Thr-389 of S6K1 is phosphorylated by PDK1 in vivo. Consistent with this idea, S6K1 is not detectably phosphorylated on Thr-389 in PDK1 Rat1-p107 cells were made quiescent by serum starvation, and then restimulated with 10% serum for the indicated times. The phosphotransferase activity of S6K1 was measured by immune complex kinase assay using an S6 peptide as substrate (Giasson and Meloche, 1995) . Results are expressed as fold stimulation over basal activity in control cells. (b) Rat1 and Rat1-p107 cells were treated as in (a). Cellular extracts were prepared and analysed by immunoblotting with anti-phospho-S6K1(Thr-389) (Cell Signaling Technology) and anti-S6K1 specific antibodies. The results are representative of three independent experiments p107 inhibits translation C Makris et al Alessi, 2000) . Our findings described above, together with these observations, point out to PDK1 as a target of p107 growth inhibitory action. We therefore examined the impact of p107 overexpression on the regulation of PDK1. There was no difference between parental and Rat1-p107 cells in the total expression level of PDK1 nor in the extent of phosphorylation of the activation loop Ser-241 (Figure 4a ). Similar observations were made on longer time courses (data not shown). One alternative mechanism is that p107 could modulate the cellular localization of PDK1 and, as a consequence, the accessibility to its substrates. To address this possibility, we monitored the recruitment of Myc-tagged PDK1 to the plasma membrane in response to growth factors using confocal microscopy. Consistent with previous studies (Anderson et al., 1998; Filippa et al., 2000) , stimulation of Rat1 cells with serum resulted in the rapid translocation of a fraction of PDK1 to the plasma membrane (Figure 4b ), which reached a maximum 5 min after serum stimulation (Figure 4c ). However, this cellular relocalization of PDK1 was severely impaired in cells overexpressing p107. Quantitative analysis revealed that PDK1 translocated to the membrane compartment in 81% of the Rat1 cells analysed at 5 min, in comparison to 19% of Rat1-p107 cells (Figure 4c ). We next attempted to rescue the p107-mediated translation defect in Rat1 cells by overexpressing PDK1. As shown in Figure 4d , expression of increasing amounts of PDK1 gradually restored the level of mRNA translation. These findings are consistent with the hypothesis that p107 negatively regulates PDK1 function by affecting its subcellular localization and preventing membrane recruitment, hence abolishing interactions with its downstream effectors. This is supported by the current model in which Akt and PDK1 are recruited to the plasma membrane, resulting in a conformational change of Akt that is required for its phosphorylation by PDK1. In contrast to Akt, S6K1 does not have a lipid-binding domain. However, it has been suggested that S6K1 can be recruited to the plasma membrane through its interaction with PKCz, and Cdc42/Rac1, and thus colocalize with its activating kinases, such as PDK1 (Martin et al., 2001; Romanelli et al., 1999) . Moreover, S6K1 can become concentrated in the inner plasma membrane (Koh et al., 1999) .
It is interesting to note that the PDK1 sequence contains the motif LXCXE (residues 325 -329) at the end of the catalytic domain (Coffer et al., 1998; Vanhaesebroeck and Alessi, 2000) . This motif, which is found in many Rb-family binding proteins, has been and Rat1-p107 cells were made quiescent by serum starvation, and then restimulated with 10% serum for the indicated times. The PI3K inhibitor LY294002 (LY) was added at a final concentration of 10 mM 30 min prior to stimulation. For assay of Akt1 activity, cellular extracts (500 mg protein) prepared in Akt lysis buffer (50 mM Tris-HCl, pH 7.4, 50 mM NaF, 50 mM Na pyrophosphate, 1 mM EGTA, 1 mM EDTA, 10 mM b-glycerophosphate, 1 mM Na orthovanadate, 1 mM okadaic acid, 0.1% bmercaptoethanol, 0.1 mM PMSF, 1 mg/ml leupeptin, 1 mM pepstatin A, 0.1% Triton X-100) were incubated for 3 h at 48C with 2 mg of anti-Akt1 antibody (Upstate Biotechnology) preadsorbed to protein G-Sepharose beads. The immune complexes were washed three times with Akt lysis buffer containing 0.5 M NaCl, and twice with kinase buffer (20 mM HEPES, pH 7.4, 10 mM MgCl 2 , 10 mM MnCl 2 , 1 mM dithiothreitol, 10 mM b-glycerophosphate, 1 mM Na orthovanadate, and 17 mM PKA inhibitor peptide). Akt1 activity was assayed by resuspending the beads in 25 ml of kinase buffer containing 5 mg histone H2B, 50 mM ATP, and 5 mCi [g- The lipid kinase activity of PI3K was assayed as described (Fukui and Hanafusa, 1989 ) using phosphatidylinositol (PI) as substrate. All the results are representative of at least three independent experiments p107 inhibits translation C Makris et al After 24 h, the cells were harvested and analysed for luciferase activity as described in Figure 1d . The activity of luciferase in vector-transfected cells was set at 100%. (e) p107 physically associates with PDK1 in vitro. CHO cells were transiently transfected with pCMV5-PDK1 and lysate proteins (2 mg) were incubated for 2 h at 48C with 3 mg of immobilized GST or GST-p107(252 -936) fusion proteins purified from E. coli. Bound proteins were washed extensively, and analysed by immunoblotting with anti-Myc (9E10) and anti-GST (Cedarlane) antibodies. Results are representative of three independent experiments p107 inhibits translation C Makris et al shown to bind with high affinity to a conserved groove in the B subdomain of the Rb pocket (Grana et al., 1998; Harbour and Dean, 2000; Mulligan and Jacks, 1998) . We found in GST pull-down experiments that PDK1 can physically associate with p107 ( Figure 4e) . However, the physiological significance of this interaction remains to be established. Previous studies have shown that p107 is mainly found in the nucleus, but that a significant fraction of the protein localizes to the cytoplasm in cycling cells (Verona et al., 1997; Zini et al., 2001) . In agreement with these findings, we also observed by immunofluorescence analysis that p107 can be detected in the cytoplasm of proliferating Rat1 cells (data not shown). The possible interaction of p107 with PDK1 provides a potential mechanism by which p107 may regulate the cellular localization, and hence the biological activity, of PDK1. The Rb family protein p107 has been shown to affect expression of genes involved in both cell cycle progression and cell biosynthetic capacity (Classon and Dyson, 2001; Sutcliffe et al., 1999) . These functions are largely dependent on its ability to associate with and regulate the activity of a growing number of cellular proteins. Here, we provide the first evidence that p107 directly inhibits mRNA translation and restricts protein synthesis in fibroblast cells. The growth inhibitory action of p107 is associated with the inhibition of PI3K signaling at the level of PDK1. Thus, our results suggest that p107 inhibits cell proliferation by restricting both cell growth and cell division cycle.
